These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23740390)

  • 21. [Zebrafish as a model animal for the study of blood-brain barrier permeability by biomolecules].
    Fu AL; Chen HY; Xu XR; Zhao BQ
    Yao Xue Xue Bao; 2012 Nov; 47(11):1447-51. PubMed ID: 23387075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in brain penetration evaluation in drug discovery and development.
    Liu X; Chen C; Smith BJ
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Blood-Brain Barrier (BBB) Score.
    Gupta M; Lee HJ; Barden CJ; Weaver DF
    J Med Chem; 2019 Nov; 62(21):9824-9836. PubMed ID: 31603678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico prediction of blood brain barrier permeability: an Artificial Neural Network model.
    Garg P; Verma J
    J Chem Inf Model; 2006; 46(1):289-97. PubMed ID: 16426064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning from our failures in blood-brain permeability: what can be done for new drug discovery?
    Martel S
    Expert Opin Drug Discov; 2015 Mar; 10(3):207-11. PubMed ID: 25658294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations.
    Carpenter TS; Kirshner DA; Lau EY; Wong SE; Nilmeier JP; Lightstone FC
    Biophys J; 2014 Aug; 107(3):630-641. PubMed ID: 25099802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist.
    Gao X; Qian J; Zheng S; Changyi Y; Zhang J; Ju S; Zhu J; Li C
    ACS Nano; 2014 Apr; 8(4):3678-89. PubMed ID: 24673594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
    Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
    Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a computational approach to predict blood-brain barrier permeability.
    Liu X; Tu M; Kelly RS; Chen C; Smith BJ
    Drug Metab Dispos; 2004 Jan; 32(1):132-9. PubMed ID: 14709630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods to assess drug permeability across the blood-brain barrier.
    Nicolazzo JA; Charman SA; Charman WN
    J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Recurrent Neural Network model to predict blood-brain barrier permeability.
    Alsenan S; Al-Turaiki I; Hafez A
    Comput Biol Chem; 2020 Dec; 89():107377. PubMed ID: 33010784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer's disease.
    Rishton GM; LaBonte K; Williams AJ; Kassam K; Kolovanov E
    Curr Opin Drug Discov Devel; 2006 May; 9(3):303-13. PubMed ID: 16729726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.
    Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A
    Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand and Structure-based Modeling of Passive Diffusion through the Blood-Brain Barrier.
    Vilar S; Sobarzo-Sanchez E; Santana L; Uriarte E
    Curr Med Chem; 2018; 25(9):1073-1089. PubMed ID: 29110594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM.
    Shaker B; Yu MS; Song JS; Ahn S; Ryu JY; Oh KS; Na D
    Bioinformatics; 2021 May; 37(8):1135-1139. PubMed ID: 33112379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling.
    Wager TT; Liras JL; Mente S; Trapa P
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):531-42. PubMed ID: 22458547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase.
    Kaya M; Ahishali B
    Methods Mol Biol; 2011; 763():369-82. PubMed ID: 21874465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis.
    Yusof SR; Avdeef A; Abbott NJ
    Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.